select trial semaglutide nejm New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj Oral and Cardiovascular Outcomes (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis Oral Semaglutide and Cardiovascular Outcomes

Additionally, patients with diabetic kidney disease or on certain blood pressure medications should work closely with providers to monitor kidney function and electrolytes

R., Rosario, F

[1] [3] According to its Summary of Product Characteristics (SmPC), it is indicated to improve glycaemic control in adults when diet and exercise alone prove insufficient, either as monotherapy when metformin is inappropriate or as an add-on therapy with other diabetes medications

What To Know Novo Nordisk also said in its announcement on Monday that for existing self-pay patients using the injections, costs will also be slashed

PCOS can lead to various health complications, such as infertility, insulin resistance, and an increased risk of type 2 diabetes and cardiovascular disease